Voisard Asset Management Group, Inc. Ionis Pharmaceuticals Inc Transaction History
Voisard Asset Management Group, Inc.
- $240 Billion
- Q3 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 10 shares of IONS stock, worth $359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$359% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$541 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$509 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$371 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$314 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$283 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.1B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...